Get startedLog in
    Picture of Icecure Medical logo

    ICCM — Icecure Medical News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: Positive Data From Icecure's Kidney Cancer Clinical Study Presented At Interventional Radiology Conference

    Picture of Icecure Medical logoIcecure Medical
    12/06/2024 13:37
    June 12 (Reuters) - Icecure Medical Ltd  ICCM.O :
    * POSITIVE DATA FROM ICECURE'S KIDNEY CANCER CLINICAL STUDY
PRESENTED AT INTERVENTIONAL RADIOLOGY CONFERENCE: MINIMALLY
INVASIVE APPROACH RESULTS IN SHORTER HOSPITALIZATION AND MINOR
IMPACT ON RENAL FUNCTION
    * ICECURE MEDICAL LTD - ICECURE'S PROSENSE SHOWS 89.5%
RECURRENCE-FREE RATE
    * ICECURE MEDICAL LTD: MORE DATA EXPECTED IN Q4, INCLUDING
DATA ON
PATIENTS WITH AN AVERAGE FOLLOW UP OF APPROXIMATELY 3 YEARS
    * ICECURE MEDICAL LTD: MORE DATA IS EXPECTED IN Q4 OF 2024

Source text for Eikon:  ID:nPn1f4sMva 
Further company coverage:  ICCM.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Icecure Medical

    See all news